0.4807  -0.029 (-5.75%)		01-26 16:00
Open: 0.493 High: 0.4999 Volume: 863,895		Pre. Close: 0.51 Low: 0.4674 Market Cap: 7(M)

Short term
Mid term
Targets	6-month :	0.64	1-year :	0.7
Resists	First :	0.54	Second :	0.6
Pivot price	0.52
Supports	First :	0.46	Second :	0.38
MAs	MA(5) :	0.5	MA(20) :	0.51
	MA(100) :	0.71	MA(250) :	1.25
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	19.8	D(3) :	20.9
RSI	RSI(14): 39.3
52-week	High :	4.13	Low :	0.46

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SCNX ] has closed below the lower bollinger band by 2.9%. Bollinger Bands are 83.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 47 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.5 - 0.5	0.5 - 0.51
Low:	0.46 - 0.46	0.46 - 0.47
Close:	0.48 - 0.48	0.48 - 0.49

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Wed, 10 Dec 2025
Why Is Scienture Stock Gaining Today? - Scienture Holdings (NASDAQ:SCNX) - Benzinga

Fri, 14 Nov 2025
Scienture Holdings stockholders approve reverse split and equity plan expansion - Investing.com

Thu, 13 Nov 2025
Scienture (NASDAQ: SCNX) launches Arbli, FDA-approved liquid losartan; revenue hits $590K - Stock Titan

Tue, 04 Nov 2025
Scienture (NASDAQ: SCNX) adds Arbli to health plan formularies, access for 100M+ lives - Stock Titan

Thu, 30 Oct 2025
Scienture Holdings increases available shares for sale under equity agreement - Investing.com

Thu, 23 Oct 2025
Why Did Scienture Stock (SCNX) Soar 45% Today? - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	41 (M)
Shares Float	34 (M)
Held by Insiders	16.8 (%)
Held by Institutions	1.4 (%)
Shares Short	2,400 (K)
Shares Short P.Month	2,160 (K)

EPS	0.75
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.56
Profit Margin	0 %
Operating Margin	-739.2 %
Return on Assets (ttm)	-10.9 %
Return on Equity (ttm)	-24.1 %
Qtrly Rev. Growth	809.7 %
Gross Profit (p.s.)	0.01
Sales Per Share	0.01
EBITDA (p.s.)	-0.43
Qtrly Earnings Growth	0 %
Operating Cash Flow	-11 (M)
Levered Free Cash Flow	2 (M)

PE Ratio	0.64
PEG Ratio	0
Price to Book value	0.13
Price to Sales	29.89
Price to Cash Flow	-1.76

Dividend	1.5
Forward Dividend	0
Dividend Yield	312%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.